Sol-Gel Technologies (SLGL) Revenue Growth (3y) (2021 - 2025)
Sol-Gel Technologies (SLGL) Revenue Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Sol-Gel Technologies | 226.64 Mn | 216.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90.93% |
| Sep 30, 2025 | 15.29% |
| Jun 30, 2025 | 69.92% |
| Mar 31, 2025 | -93.00% |
| Dec 31, 2024 | -76.27% |
| Sep 30, 2024 | 58.91% |
| Jun 30, 2024 | 80.23% |
| Dec 31, 2023 | -39.88% |
| Sep 30, 2023 | -53.48% |
| Jun 30, 2023 | -19.37% |
| Dec 31, 2022 | -70.81% |
| Sep 30, 2022 | -61.94% |
| Jun 30, 2022 | -23.29% |
| Mar 31, 2022 | 678.51% |
| Dec 31, 2021 | 2,083.17% |
| Sep 30, 2021 | 227.60% |
| Jun 30, 2021 | 166.55% |
| Mar 31, 2021 | 151.63% |